AOL Web Search

All flu vaccines for the 2022-2023 season will be quadrivalent (four component). Most will be thimerosal-free or thimerosal-reduced vaccine (93%), and about 20% of flu vaccines will be egg-free. Influenza vaccine distribution information for the 2022-2023 season will be posted here as CDC receives it, typically on Fridays.

Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced the initiation of a Phase 2 trial for its COVID-19-Influenza Combination and influenza stand-alone vaccine candidates.

Novavax should be able to make multiple strains, since they overestimated their sales and overbuilt factories. Making 4 strains to sell 1 or 2 isn't cost-efficient, but Pfizer and Moderna boosted their vax prices 4x, so similar pricing might give Novavax the margin it needs!

The FDA said it envisioned holding a meeting later in the year to determine the composition of shots for the fall, although some vaccine makers might be able to produce updated shots more quickly. Pfizer/BioNTech and Moderna were able to produce the currently available messenger RNA boosters in about three months last year, but Novavax Inc said on Thursday it would require six months to make a ...

Jan 22, 2023 by Adria Cimino AbbVie Is Set to Lose on Its Biggest Blockbuster. Here's Why You Shouldn't Worry. Two newer immunology drugs look like big tickets to growth. Jan 20, 2023 by Adria...

Novavax GAAP EPS of -$2.15 misses by $3.79, revenue beats estimates, lowers revenue guidance. SA NewsTue, Nov. 08, 2022 35 Comments.

You are recommended to get a booster dose if it has been between three and six months after symptom onset or a positive test, However, waiting six months may provide a better immune response. Children aged six months and older can receive a COVID-19 vaccine at the same time as, or at any time before or after other vaccines, including the flu shot.

Novavax submits COVID-19 vaccine for approval by Health Canada November 1, 2021 Market movers: Stocks that saw action on Monday - and why June 14, 2021 Novavax’s COVID-19 vaccine more than 90%...